CEO-founder at Groupe Fuga, a producer of medical cannabis in small batches.
A start-up company, Groupe Fuga has strong ambitions to position itself as a unique player in the Canadian medical cannabis market. It will distinguish itself by its “lifestyle” approach and highly rigorous quality control of its products. By acquiring a research license in addition to a cultivation license, Fuga will be able to work on developing its own high-quality cannabis essences. Well-being is at the centre of its interests, whether it is the client it will serve, its employees or the environments in which it will establish itself.